Coolbally Investments Limited
Investment Details
Investor Type
Family Office
Asset Class Focus
Private Equity, Venture Capital
Stage Focus
Early Stage, Growth, Late Stage
Geographical Focus
United States, United Kingdom, Canada, Germany, Japan, Australia, France, Italy, Denmark, Switzerland, Spain, South Korea, Ireland, Austria, Netherlands, New Zealand, Sweden, Belgium, Norway, Finland
Industries Focus
- Financial Services
- Technology
- Healthcare
- Energy
- Consumer Goods
- Real Estate
- Telecommunications
- Utilities
- Media
- Retail
- Software
- Education
- Agriculture
- Logistics
- Transportation
- Pharmaceuticals
- Medical Devices
- Entertainment
- Biotechnology
- Chemicals
Investment Size:
1,000,000 to 50,000,000 USD
Investor Details Founded: 2018
Coolbally Investments Limited is a private investment firm based in Dublin, Ireland, founded by Tom Brennan, the co-founder of EirGen Pharma. The firm specializes in private equity and venture capital investments, focusing on early-stage, growth, and late-stage opportunities across a diverse range of industries, including pharmaceuticals, biotechnology, healthcare, and technology. Coolbally Investments Limited has a strong geographical focus, with investments spanning Ireland, the United States, Canada, and several European countries, reflecting its commitment to supporting innovative companies in both domestic and international markets.
The firm's investment strategy is characterized by a hands-on approach, leveraging Tom Brennan's extensive experience in the pharmaceutical and biotechnology sectors to identify and nurture high-potential companies. This approach has led to successful investments in companies such as Shorla Oncology, a pharmaceutical firm specializing in oncology treatments, where Coolbally Investments Limited participated in a $35 million Series B funding round. Additionally, the firm has been involved in the development and growth of EirGen Pharma, a company founded by Tom Brennan and Patsy Carney, which was acquired by OPKO Health in 2015 for $135 million.
Coolbally Investments Limited's track record demonstrates a commitment to fostering innovation and growth in the sectors it invests in. By providing strategic guidance, operational support, and access to a broad network of industry contacts, the firm aims to enhance the value and impact of its portfolio companies, contributing to advancements in healthcare, technology, and other key industries. This approach underscores the firm's dedication to creating long-term value for its investors and the communities its portfolio companies serve.
Requirements
- Strong management team
- Innovative business model
- Scalable operations
- Clear path to profitability
- Competitive market positioning
- Potential for significant growth
- Alignment with firm's strategic focus areas
- Ability to leverage firm's industry expertise
- Commitment to ethical business practices
- Demonstrated market demand for product or service
Contact
[HQ Location Hidden]
Portfolio Companies
- Shorla Oncology
- EirGen Pharma
Claim this Investor
Are you an official representative of Coolbally Investments Limited?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim